JAY S. SKYLER - 03 May 2024 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Jay S. Skyler
Issuer symbol
SABS
Transactions as of
03 May 2024
Net transactions value
$0
Form type
3
Filing time
14 May 2024, 17:00:06 UTC
Previous filing
08 Jun 2023
Next filing
07 Jun 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.